You are currently browsing the tag archive for the ‘ESC’ tag.

European Stroke Conference  #ESOC14 #eurostroke14 in Nice

#ESOC14 en còte d’azur

Advertisements

Neurology meeting in Perugia under the patronage of the Società Italiana di Neurologia. Hosted by the Neurolgy Department University of Perugia, Paolo Calabresi, Aroldo Rossi, Lucilla Parnetti, Nicola Tambasco.
First ever as far as i know. I can remember in 1996 a joint tosco-umbro meeting at palazzo Murena.

dicembre2013 262

dicembre2013 263

dicembre2013 264

dicembre2013 265

dicembre2013 269

dicembre2013 270

dicembre2013 272

dicembre2013 273

dicembre2013 274

Starting on 29 May 2013 with many Oral Sessions fresh updates on Stroke Large clinical trials (RCTs)
at 11:25-12:30 Room: Auditorium INTERACT2, STICH II, CHIMES, IST-3, SPS3, next day PC-Trial, RESPECT, ALIAS, PHANTOM-S, ICSS, EVA-3S, STICH II.
lamp

Image

At ESC 2012 Lisbon, everyone’s talking about IST-3 the positive effects on acute ischemic stroke are mostly within 3 hours. But aged subjects may be more likely to be treated now.

INTERACT 2 trial is likely to be soon closed for reaching the enrollement goal.

The ICTUS trial demonstrated NO effects of citicoline in acute stroke.

ESO committees were also renewed.

Ist 3 trial results will be presented in the next European Stroke conference meeting held in Lisbon on 22-25 May. With more than 3000 enrolled patients this is likely to be one of the larget acute stroke trials. Check out the official site and preliminary publications on Trials. 2011 Nov 30;12:252.

and the winner is…. I extrapolated 220.000 € to Spanish projects while                                100.000 to Italy, Romania, Belg…

Paris, France and Ingelheim, Germany, 29th August 2011 – Last night at an award ceremony in Paris, the 32 winning projects of the global disease awareness initiative 1 Mission 1 Million – Getting to the Heart of Stroke were announced. The projects were chosen by the public and a panel of experts. They will be awarded a share of the €1 million donation to fulfil the overall mission of preventing as many as one million atrial fibrillation (AF)-related strokes through awareness campaigns. 1 Mission 1 Million is supported by over 45 third-party organisations around the world and is sponsored by Boehringer Ingelheim.